TY  - GEN
AU  - Shacham-Shmueli,Einat
AU  - Geva,Ravit
AU  - Figer,Arie
AU  - Bulocinic,Sarah
AU  - Nalbandyan,Karen
AU  - Shpigel,Shulim
AU  - Atsmon,Jacob
AU  - Brendel,Erich
TI  - Phase I trial of sorafenib in combination with 5-fluorouracil/leucovorin in advanced solid tumors
SN  - 1552-4604
PY  - 2012///0821
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Area Under Curve
KW  - Benzenesulfonates
KW  - Drug Administration Schedule
KW  - Drug Interactions
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Infusions, Intravenous
KW  - Injections, Intravenous
KW  - Israel
KW  - Leucovorin
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Sorafenib
KW  - Treatment Outcome
KW  - Vitamin B Complex
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1177/0091270011404027
ER  -